Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
Clinical trial NCT07522151 · RECRUITING
Trial details
- NCT number
- NCT07522151
- Sponsor
- Shanghai Shengdi Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-07
- Primary completion
- 2029-12-01
- Enrollment
- 874
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.